MS1819-SD

MS1819-SD · AzurRx SAS

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MS1819-SD, covering 2018-09-28 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs [Phase 2]